Publication Topic

Haws LC, Thompson C, Perry C, White M, Fitzgerald L, Borghoff S, Wikoff D. Development of non-cancer based toxicity factors and daily dose estimates for TBBPA. Presented at Society of Toxicology 53rd Annual Meeting, Phoenix, AZ, March 2014.

Erichsen R, Kelsh MA, Oliner KS, Nielsen KB, Frøslev T, Lænkholm AV, et al. Prognostic impact of tumor MET expression among patients with stage IV gastric cancer: A Danish cohort study. Presented at International Conference on Pharmacoepidemiology and Therapeutic Risk Management (ICPE), Taipei, Taiwan, October 28–30, 2014.

Thompson CM, Kirman CR, Proctor DM, Haws LC, Suh M, Hays S, Hixon JG, Harris MA. 2014. A chronic oral reference dose for hexavalent chromium-induced intestinal cancer. J Appl Toxicol 34(5):525-536. doi: 10.1002/jat.2907. PMID: 23943231.

Gentry R, Clewell H, Greene T, Franzen A, Yager J. 2014. The impact of recent advances in research on arsenic cancer risk assessment. Regul Toxicol Pharmacol 69(1):91–104; 10.1016/j.yrtph.2014.02.006.

Jensen IS, Halbert RJ, Thompson SF, Hennessy D, Pacconi S, McSweeney PA. Increased use of plerixafor in patients with multiple myeloma and non-Hodgkin’s lymphoma in the United States: A budgetary impact analysis. Abstract C14, Academy of Managed Care Pharmacy 26^th Annual Meeting & Expo, 2014.

Wikoff D, Thompson C, Perry C, White M, Fitzgerald L, Borghoff S, Haws LC. Development of an oral cancer slope factor and lifetime average daily dose estimates for TBBPA. Presented at Society of Toxicology 53rd Annual Meeting, Phoenix, AZ, March 2014.

Chia VM, O’Malley CD, Danese MD, Lindquist KJ, Gleeson ML, Kelsh MA, et al. 2013. Prevalence and incidence of comorbidities in elderly women with ovarian cancer. Gynecol Oncol 129(2):346–352; doi: 10.1016/j.ygyno.2013.02.014. PMID: 23422502.

Lowe KA, Chia VM, Taylor A, O’Malley C, Kelsh M, Mohamed M, et al. 2013. An international assessment of ovarian cancer incidence and mortality. Gynecol Oncol 130(1):107–114; doi: 10.1016/j.ygyno.2013.03.026. PMID: 23558050.

Fryzek J, Pastula S, Jiang X, Garabrant DH. 2013. Childhood cancer incidence in Pennsylvania counties in relation to living in counties with hydraulic fracturing sites. J Occup Environ Med 55(7):796–801; doi: 10.1097/JOM.0b013e318289ee02. PMID: 23836020.

Urban JD, Thompson CM, Deskin R, Waite M, Haws LC. 2013. Development of an oral cancer slope factor for acrylamide based on tumors relevant to humans. Presented at Society of Toxicology 52nd Annual Meeting, San Antonio, TX, March 2013.

Proctor DM, Suh M, Thompson CM, Harris MA. 2013. Mode of action evaluation for hexavalent chromium-induced lung cancer. Presented at Society of Toxicology 52nd Annual Meeting, March 10-14, San Antonio, TX.

Lamm SH, Britt JK, James RC. Multiple myeloma risk and benzene exposure among pliofilm workers – A re-analysis using an internal reference group. Presented at Society of Toxicology 52nd Annual Meeting, March 10-14, San Antonio, TX, March 2013.

Mitchell M, Lowe K, Fryzek J. 2012. A multisource approach to improving epidemiologic estimates: Application to global B-cell malignancies. ISRN Oncol 2012:129713; 10.5402/2012/129713.

Chia VM, O’Malley CD, Danese M, Lindquist K, Gleesen M, Kelsh MA, et al. Comorbid conditions in elderly women with and without ovarian cancer. Presented at International Gynecological Cancer Society Annual Meetings, Vancouver, Canada, October 13–16, 2012.

Chia VM, Lowe KA, O’Malley CD, Kelsh MA, Taylor A, Mowat F, et al. An updated assessment of global ovarian cancer trends. Presented at International Gynecological Cancer Society Annual Meetings, Vancouver, Canada, October 13–16, 2012.

Alexander D, Weed D, Mink P, Mitchell M. 2012. A weight-of-evidence review of colorectal cancer in pesticide applicators: The agricultural health study and other epidemiologic studies. Int Arch Occup Environ Health 85(7):715–745; doi: 10.1007/s00420-011-0723-7. PMID: 22159924.

Kanas GP, Taylor A, Primrose JN, Langeberg WJ, Kelsh MA, Mowat FS, et al. 2012. Survival after liver resection in metastatic colorectal cancer: review and meta-analysis of prognostic factors. Clin Epidemiol 4(1):283–301.

Mitchell M, Taylor A, Lowe K, Langeberg W, et al. Prevalence of bone metastasis in breast cancer patients and subsequent survival: A systematic and quantitative review of the literature. Presented at the San Antonio Breast Cancer Symposium, San Antonio, TX, December 2011

Mitchell M, Taylor A, Lowe K, Langeberg W, Alexander D, Kelsh M, et al. Breast cancer bone metastasis prevalence and survival outcomes: A quantitative review of the literature. Presented at the 34th Annual San Antonio Breast Cancer Symposium, San Antonio, TX, December 6–10, 2011.

Lau EC, Mowat FS, Kelsh MA, Legg JC, Engel-Nitz NM, Watson HN, et al. 2011. Use of electronic medical records (EMR) for oncology outcomes research: Assessing the comparability of EMR information to patient registry and health claims data. Clin Epidemiol 3:259–272.